Medtronic has appointed John Groetelaars and Bill Jellison to its board as independent directors, effective immediately, and formed two board committees.

Medtronic reported strong first-quarter 2026 results, with sales hitting $8.58 billion, surpassing the consensus estimate of ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the Medtronic Board of Directors has appointed John Groetelaars and Bill Jellison as independent directors, ...

Q1 2026 Earnings Call Transcript August 19, 2025 Medtronic plc beats earnings expectations. Reported EPS is $1.26, ...

“Our decision to become one of Medtronic’s largest investors was driven by our strong conviction that the company is entering ...

Medtronic(NYSE:MDT) reported first quarter fiscal 2026 results on August 19, 2025, delivering 4.8% year-over-year organic revenue growth and adjusted earnings per share (EPS) of $1.26, which beat the ...

Medtronic officials today said that the company's planned separation of its Diabetes business is on the right track.

CEO Geoff Martha told investors that the initiatives were done in partnership with the activist investor firm Elliott ...

"Are we investing enough behind these big growth drivers? We think no. We want to invest more," Medtronic CEO Geoff Martha ...

Medtronic has agreed to not only expand the size of its board of directors, but to also task it with taking a closer look at ...

Medtronic said on Tuesday it would add two new directors to its board and set up committees to help boost its lagging shares ...

Medtronic plc (NYSE:MDT) announced key board appointments on Tuesday, naming John Groetelaars and Bill Jellison as ...